BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has retained FischTank Marketing and PR, a New York City-based firm, as its Agency of Record to conduct national and trade media outreach, generate awareness for its upcoming Regulation A+ equity crowdfunding campaign, and advise on all marketing and communications functions.
The relationship was established to support the company as it seeks to raise its profile ahead of its equity fund raise in early 2018, and as it develops messaging and marketing strategy to generate awareness within the medical community. FischTank will seek to increase BIOLIFE4D’s overall exposure, develop and maintain external communications, and hone marketing strategies.
“As we continue to develop our technology and prepare for our Regulation A+ raise in early 2018, we felt it was crucial to establish a strong and consistent marketing and communications strategy, for both potential investors and key partners within the medical community,” said Steven Morris, CEO, BIOLIFE4D. “FischTank has the depth of experience we are looking for, having led biotech startups through this process before, with showcased results. We look forward to their guidance during this important time for our Company.”
“What BIOLIFE4D is doing from an innovation standpoint is remarkable and something we are excited to be a part of—literally giving people the gift of time,” said Matthew Bretzius, President, FischTank Marketing and PR. “We look forward to working with the team to develop a sound messaging strategy and to generate awareness for the technology and the RegA+ fund raise, but also for general heart health.”
